Repare Therapeutics Inc. — Director's Dealing 2020

Jun 25, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Repare Therapeutics Inc. (RPTX)
CIK: 0001808158
Period of Report: 2020-06-23

Reporting Person: Foley Todd (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-06-23	Common Shares	C	1801581	—	Acquired	1801581	Indirect
2020-06-23	Common Shares	C	952191	—	Acquired	2753772	Indirect
2020-06-23	Common Shares	P	250000	$20.00	Acquired	3003772	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-06-23	Class A Preferred Shares	$	C	1801581	Disposed		Common Shares (1801581)	Indirect
2020-06-23	Class B Preferred Shares	$	C	952191	Disposed		Common Shares (952191)	Indirect

Footnotes

F1: All series of convertible preferred shares converted into the number of shares of the Issuer's common shares on a 1-for-1 basis, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering and had no expiration date.

F2: The shares are held as follows: 1,636,136 by MPM BioVentures 2014, L.P. ("BV 2014"), 109,128 by MPM BioVentures 2014(B), L.P. ("BV 2014(B)") and 56,317 by MPM Asset Management Investors BV2014 LLC ("AM BV2014"). MPM BioVentures 2014 GP LLC and MPM BioVentures 2014 LLC ("BV LLC") are the direct and indirect general partners of BV 2014 and BV 2014(B). Todd Foley is a managing director of BV LLC and a member of AM BV2014.

F3: The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.

F4: The shares are held as follows: 2,500,885 by BV 2014, 166,805 by BV 2014(B) and 86,082 by AM BV2014.

F5: The shares were purchased as follows: 227,042 by BV 2014, 15,143 by BV 2014(B) and 7,815 by AM BV2014.

F6: The shares are held as follows: 2,727,927 by BV 2014, 181,948 by BV 2014(B) and 93,897 by AM BV2014.

F7: No securities held by the Reporting Person.